T1D Therapeutics: Two Health Transformers Tackle Type 1 Diabetes at the Source
Join StartUp Health NOW for a groundbreaking episode exploring the latest advancements in Type 1 diabetes research. We delve into our T1D Moonshot Community dedicated to improving detection, management, and treatment of the disease, and uncover promising developments on the therapeutic front.
Hear from leading innovators:
- Warren Marcus, PhD, CEO & Founder of WiNK Therapeutics, shares insights on his mission to cure Type 1 diabetes using the body’s own beta islet cells.
- Mike Moradi, CEO & Co-founder of Sensulin, discusses the creation of a glucose-responsive insulin for personalized diabetes management.
Discover:
- The cutting-edge technologies shaping the future of Type 1 diabetes treatment
- The progress being made towards a potential cure
- The impact these innovations can have on the lives of people with diabetes
This episode is a must-listen for anyone interested in diabetes research, healthcare innovation, and the inspiring work of entrepreneurs making a difference.
Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot.
Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
